Come up with a name for your new list and we'll add to it:
Entrega raised a round of funding on December 19, 2017. Investors include
Eli Lilly & Co..
Entrega is focused on the oral delivery of complex molecules, such as peptides, that cannot currently be taken orally. Entrega leverages a technology platform which uses a proprietary, customizable hy…